KOL strategy – Thought Leader Select

Thought Leader Select’s Meade to Address ExL Pharma KOL Conference

Thought Leader Select continues with a busy summer schedule of conference sponsorships, with the company’s support of ExL Pharma’s Fifth KOL Relationship Summit in Philadelphia. Paul Meade, founder and President of Thought Leader Select, will address attendees at one of the must-attend events for American life sciences companies, coming on the heels of the company’s …

Thought Leader Select’s Meade to Address ExL Pharma KOL Conference Read More »

Thought Leader Select Lands New KOL Strategy Engagement in Diabetes

Uncategorized / By bcastle

October 3, 2013 (CHAPEL HILL, NC) Thought Leader Select has accepted a new key opinion leader (KOL) strategy engagement with a global biopharmaceutical leader in the treatment area of diabetes. The client company, one of the world’s top five industry leaders in the development of medications for managing type I and type II diabetes, tabbed North …

Thought Leader Select Lands New KOL Strategy Engagement in Diabetes Read More »

Biopharma Leader Chooses Thought Leader Select for KOL Initiatives in Bacterial Infections

Uncategorized / By bcastle

September 26, 2013 (CHAPEL HILL, NC) A global biopharmaceutical leader recently tabbed North Carolina’s Thought Leader Select to assist the company with an upcoming slate of key opinion leader (KOL) initiatives in the area of bacterial infections. The KOL initiatives will support a developing portfolio of intravenous treatments for certain bacterial infections. Thought Leader Select, headquartered in Chapel …

Biopharma Leader Chooses Thought Leader Select for KOL Initiatives in Bacterial Infections Read More »

Thoughts on the MSL Society’s Inaugural Conference

Uncategorized / By bcastle

Industry Insights from Paul Meade, M.Sc, MPH Allison Murphy and I had the pleasure of participating in the MSL Society’s inaugural global conference and gala in Philadelphia earlier this month. At Thought Leader Select, we always enjoy the opportunity to meet some of our great colleagues in medical affairs in the pharmaceutical, biotechnology, and device …

Thoughts on the MSL Society’s Inaugural Conference Read More »

Top US Pharma Chooses Thought Leader Select for Obesity Centers of Excellence Initiative

Uncategorized / By bcastle

October 18, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement focused on medical centers of excellence in obesity with a top U. S. biopharmaceutical company. The company, part of a select group of global leaders in …

Top US Pharma Chooses Thought Leader Select for Obesity Centers of Excellence Initiative Read More »

Top 10 Global Biopharmaceutical Company Tabs Thought Leader Select for Infectious Disease Partnership

Uncategorized / By bcastle

April 26, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of an inter-disciplinary infectious disease engagement with a top 10 global biopharmaceutical company. The biopharmaceutical company, part of a select group of global leaders in drug development for the …

Top 10 Global Biopharmaceutical Company Tabs Thought Leader Select for Infectious Disease Partnership Read More »

The Thought Leaders Driving Thought Leader Select: A Blog Series—Neil Mellor

Uncategorized / By bcastle

Neil Mellor joined Thought Leader Select as its principal business development agent for North America in the spring of 2009. Neil spent over 20 years working at the highest levels of the pharmaceutical industry, including a stint as vice president of business development at Spexell Pharma, a Canadian specialty firm. Mellor has also worked as …

The Thought Leaders Driving Thought Leader Select: A Blog Series—Neil Mellor Read More »